These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 1372339)
1. Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. Pincelli C; Fantini F; Romualdi P; Sevignani C; Lesa G; Benassi L; Giannetti A J Invest Dermatol; 1992 Apr; 98(4):421-7. PubMed ID: 1372339 [TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal polypeptide stimulates the proliferation of HaCaT cell via TGF-alpha. Sung KJ; Chang SE; Paik EM; Lee MW; Choi JH Neuropeptides; 1999 Dec; 33(6):435-46. PubMed ID: 10657522 [TBL] [Abstract][Full Text] [Related]
4. The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human keratinocytes. Park YM; Kim CW J Dermatol Sci; 1999 Dec; 22(1):17-23. PubMed ID: 10651225 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Naukkarinen A; Harvima I; Paukkonen K; Aalto ML; Horsmanheimo M Arch Dermatol Res; 1993; 285(6):341-6. PubMed ID: 7692828 [TBL] [Abstract][Full Text] [Related]
6. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Chan J; Smoller BR; Raychauduri SP; Jiang WY; Farber EM Arch Dermatol Res; 1997 Oct; 289(11):611-6. PubMed ID: 9444383 [TBL] [Abstract][Full Text] [Related]
7. Double-labeled immunofluorescence study of cutaneous nerves in psoriasis. Jiang WY; Raychaudhuri SP; Farber EM Int J Dermatol; 1998 Aug; 37(8):572-4. PubMed ID: 9731999 [TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Haegerstrand A; Jonzon B; Dalsgaard CJ; Nilsson J Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5993-6. PubMed ID: 2474824 [TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Giannetti A; Fantini F; Cimitan A; Pincelli C Acta Derm Venereol Suppl (Stockh); 1992; 176():90-2. PubMed ID: 1282289 [TBL] [Abstract][Full Text] [Related]
10. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors. Takahashi K; Nakanishi S; Imamura S J Invest Dermatol; 1993 Nov; 101(5):646-51. PubMed ID: 8228323 [TBL] [Abstract][Full Text] [Related]
11. Quantitative histochemical analysis of mast cells and sensory nerves in psoriatic skin. Naukkarinen A; Järvikallio A; Lakkakorpi J; Harvima IT; Harvima RJ; Horsmanheimo M J Pathol; 1996 Oct; 180(2):200-5. PubMed ID: 8976881 [TBL] [Abstract][Full Text] [Related]
12. Psoriatic keratinocytes express high levels of nerve growth factor. Raychaudhuri SP; Jiang WY; Farber EM Acta Derm Venereol; 1998 Mar; 78(2):84-6. PubMed ID: 9534881 [TBL] [Abstract][Full Text] [Related]
13. Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. Eedy DJ; Johnston CF; Shaw C; Buchanan KD J Invest Dermatol; 1991 Apr; 96(4):434-8. PubMed ID: 2007781 [TBL] [Abstract][Full Text] [Related]
14. Effects of peptide T derivatives on the proliferation of cultured human keratinocytes. Marastoni M; Scaranari V; Fantini F; Sevignani C; Tomatis R Arzneimittelforschung; 1995 Aug; 45(8):891-3. PubMed ID: 7575755 [TBL] [Abstract][Full Text] [Related]
15. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin. Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M Int J Dermatol; 1994 May; 33(5):361-6. PubMed ID: 8039976 [TBL] [Abstract][Full Text] [Related]
16. Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Anand P; Springall DR; Blank MA; Sellu D; Polak JM; Bloom SR Br J Dermatol; 1991 Jun; 124(6):547-9. PubMed ID: 1712221 [TBL] [Abstract][Full Text] [Related]
17. Differential effect of vasoactive intestinal peptide, somatostatin, and substance P on human IgE and IgG subclass production. Kimata H; Yoshida A; Ishioka C; Mikawa H Cell Immunol; 1992 Oct; 144(2):429-42. PubMed ID: 1382870 [TBL] [Abstract][Full Text] [Related]
18. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178 [TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide and inflammatory cytokines enhance vascular endothelial growth factor production from epidermal keratinocytes. Kakurai M; Demitsu T; Umemoto N; Kobayashi Y; Inoue-Narita T; Fujita N; Ohtsuki M; Furukawa Y Br J Dermatol; 2009 Dec; 161(6):1232-8. PubMed ID: 19785602 [TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide induces vascular endothelial growth factor production in human HaCaT keratinocytes via MAPK pathway. Yu XJ; Ren XH; Xu YH; Chen LM; Zhou CL; Li CY Neuropeptides; 2010 Oct; 44(5):407-11. PubMed ID: 20627382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]